Karchmer KS

Language: Spanish
References: 32
Page: 37-46
PDF size: 111.78 Kb.

ABSTRACT

Most reproductiv age women, before or during pregnancy, experience fear and anxiety regarding the possibility of carrying a baby with genetic abnormalities. The opportunity of having a prenatal diagnosis during early stages of pregnancy has increased the number of voluntary interruptions of pregnancy. Many circumstances have been exposed to explain or justify a medically indicated abortion. Routinely, those indications based on scientific and technological advances are exeptional; nevertheless, the fact that only one of these indications may be potentially present forces the use of the term "therapeutic abortion". Therapeutic abortion -and abortion in general- is a controversial issue. As long as our institutions and societies continue avoiding the search for an intermediate position that may allow to reach and agreement, and only moral and antagonistic thesis previal, the problem will continue, taking away human lives.
New assisted reproduction techniques have became increasingly common in today's world. The fact that irregular practices and abuses exist, does not necerrarily mean that progress in this field should be stopped. Therefore, it is important toavoid turning the fact of having a child into a laboratory matter or considering women just in terms of their reproductive capacity rather than as human beings.

REFERENCES

1. Karchmer S. El diagnóstico prenatal. Rev Med Soc 1989;3:3-8.

2. Karchmer S. Aspectos sociomédicos del diagnóstico prenatal. Prog Diag Prenat 1995;7:360-362.

3. Karchmer S. ¿A dónde nos llevará la genética en el diagnóstico prenatal? Prog Diag Prenat 1998;10:136-146.

4. Henshaw SK. Induced abortion: a world review 1990. Fam Plann Perspec 1990;22:76-89.

5. David HP. Abortion in Europe, 1920-91: a public health perspective. Stud Fam Plann 1992;23:1-22.

6. Mundarin AJ. Aborto terapéutico por indicación médico-materna. Rev Obst Ginec Venezuela 1981;41:153.

7. White P. Pregnancy complicating diabetes. Am J Med 1949;7:609.

8. Devoe LD, Taylor R. Systemic lupus erythematosus in pregnancy. Am J Obstet Gynecol 1979;135:473.

9. Gleicher N, Elkayam U. Fertility control in the cardiac patient. In: Elkayam U. Gleicher N, editors. Cardiac problem in pregnancy. 2nd ed. New York: Alan R. Liss;1990. p.453.

10. Dibble CM, Kockenour NK, Wosley RT, et al. Effect of pregnancy on diabetic retinopathy. Obstet Gynecol 1982;59:699.

11. Centers for Disease Control and Prevention. 1995. Assisted reproductive technology success rates: national summary and fertility clinic reports. Atlanta, GA, USA: CDC;1998.

12. Karchmer S. Consideraciones éticas sobre las nuevas formas de fertilización y diagnóstico prenatal. Perin Rep Hum 1988; 2:193-197.

13. Evans MI, Fletcher JC, Zador IE, Newton BW, Quigg MH, Struyk CD. Selective first trimester termination in octuplet and quadruplet pregnancies: clinical and ethical issues. Obstet Gynecol 1988;71:289-296.

14. Collins MS, Bleyl JA. Seventy-one quadruplet pregnancies: management and outcome. Am J Obstet Gynecol 1990;162:1384-1391.

15. Evans MI, Dommergues M, Wapner RJ, Goldberg JD, Lynch L, Zador IE, et al. International, collaborative experience of 1789 patients having multifetal pregnancy reduction: a plateauing of risks and outcomes. J Soc Gynecol Invest 1999;3:23-26.

16. Garel M, Starck C, Blondel B, Lefebvre G, Vauthier Brouzes D, Zorn JR. Psychological effects of embryonal reduction: from the decision making to four months after delivery. J Gynecol Obstet Biol Reprod (Paris) 1995;24:119-126.

17. Zaner RM, Boehm FH, Hill GA. Selective termination in multiple pregnancies: ethical consideration. Fertil Steril 1990;54:203-205.

18. Recommendations on ethical issues in obstetrics and gynecology. International Federation of Gynecology and Obstetrics (FIGO);September 1994.

19. The Alan Guttmacher Institute. Aborto clandestino: una realidad Latinoamericana. New York: The Alan Guttmacher Institute;1994.

20. Castelazo AL, Gaslonde S, MacGregor C, Shor PV, Ordoñez BR. Algunos aspectos de actualidad en el aborto inducido (Simposio). Gac Med Mex 1974;108:309-339.

21. Francome C, Savage WD. Gynaecologists' abortion practice. Br J Obstet Gynaecol 1992;99:153-157.

22. Nathanson CA, Becker MH. The influence of physicians' attitudes on abortion performance. Fam Plann Perspect 1977;9:158-163.

23. Evans MI, Drugan A, Bottoms SF, Platt LD, Rodeck CA, Hansman M, et al. Attitudes on the ethics of abortion, sex selection, and selective pregnancy termination among health professionals, ethicists, and clergy likely to encounter such situations. Am J Obstet Gynecol 1991;174(4):1092-1099.

24. González de León-Aguirre D. Los médicos y el aborto. Salud Public Mex. 1995;37:248-255.

25. Código Penal para el Distrito Federal. 46ª Edición. México, D.F.: Ed. Porrúa, 1990. Originalmente publicado en la sección tercera del Diario Oficial, Agosto 14, 1931.

26. Chevernak FA, McCallough LB. Does obstetric ethics have any role in the obstetrician’s reponse to abortion controversy? Am J Obstet Gynecol 1990;163:1425-1429.

27. Imber JB. Abortion policy and medical practice. Society 1990;27-34.

28. Weisman CS, Nathanson CA, Teitelbaum MA, Chase GA, King TM. Abortion attitudes and performance among male and female obstetrician-gynecologists. Fam Plann Perspect 1986;18:67-73.

29. Westfall JM, Kallail KJ, Walling AD. Abortion attitudes and practices of family and general physicians. J Fam Pract 1991;33:47-51.

30. Núñez L, Palma Y. El aborto en México. Problema social y de salud pública. Demos, Carta Demográfica sobre México 1990;3:31-33.

31. Ramos S, Viladrich A. Aborto en América Latina, cómo seguir. Revista de la Red de Salud de las Mujeres Latinoamericanas y del Caribe/ISIS Internacional 1992;4:55-64.

32. Saade A. El aborto provocado: una vía de liberación femenina? Rev Med Hosp Mex 1994;57:88-89.